Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Harrow Health ( (HROW) ) has issued an update.
On September 26, 2025, Harrow, Inc. hosted its Investor Day, during which the company presented an investor presentation that was also used in subsequent investor meetings. The presentation was made available as part of a Current Report on Form 8-K, but the information is not considered filed under the Securities Exchange Act of 1934 or the Securities Act of 1933.
The most recent analyst rating on (HROW) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
Harrow Health’s overall stock score is driven by strong earnings call results and positive technical indicators, indicating growth potential. However, significant financial performance challenges and valuation concerns weigh heavily on the score. Addressing cash flow issues and improving profitability are crucial for enhancing financial stability.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Average Trading Volume: 568,799
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.77B
See more insights into HROW stock on TipRanks’ Stock Analysis page.